Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,140.70Prev. Close
1,163.80Volume
0Total traded value
NAUpper Circuit
1,396.50Lower Circuit
931.10Fundamentals
| Market Cap | ₹346Cr |
| ROE | 10.23% |
| P/E Ratio(TTM) | 21.62 |
| EPS(TTM) | 52.98 |
| P/B Ratio | 1.76 |
| Dividend Yield | 0.13% |
| Industry P/E | 34.73 |
| Book Value | 650.15 |
| Debt to Equity | 0.44 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Haleos Labs
SMS Lifesciences is a leading Indian manufacturer of Active Pharmaceutical Ingredients (APIs) and their intermediates, with major products like Ranitidine HCL and Famotidine. The company focuses on developing products and processes according to industry benchmarks, aiming for sustained improvements and the delivery of high-quality goods. For the 2024 fiscal year, the company reported a significant standalone Earnings Per Share (EPS) growth of 19% compared to the previous year.;
| Parent Organisation | Haleos Labs |
| Managing Director | Shri. Veeravenkata Tallurl |
| NSE Symbol | SMSLIFE |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 91.44 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.79 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.00 | ||
| Wockhardt | NA (0.00%) | -142.48 |